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Abstract
The canonical Wnt signal pathway plays a pivotal role in anteroposterior patterning and midbrain speciﬁcation during
early neurogenesis. Activating Wnt signal has been a strategy for differentiating human pluripotent stem cells (PSCs)
into midbrain dopaminergic (DA) neurons; however, the underlying molecular mechanism(s) of how the Wnt signal
drives posterior fate remained unclear. In this study, we found that activating the canonical Wnt signal signiﬁcantly
upregulated the expression of EN1, a midbrain-speciﬁc marker, in a ﬁbroblast growth factor signal-dependent manner
in human PSC-derived neural precursor cells (NPCs). The EN1 promoter region contains a putative TCF4-binding site
that directly interacts with the β-catenin/TCF complex upon Wnt signal activation. Once differentiated, NPCs treated
with a Wnt signal agonist gave rise to functional midbrain neurons including glutamatergic, GABAergic, and DA
neurons. Our results provide a potential molecular mechanism that underlies midbrain speciﬁcation of human PSC-
derived NPCs by Wnt activation, as well as a differentiation paradigm for generating human midbrain neurons that
may serve as a cellular platform for studying the ontogenesis of midbrain neurons and neurological diseases relevant
to the midbrain.
Introduction
The midbrain is a portion of the central nervous system
that develops between the diencephalon and the hind-
brain and contains numerous relay centers for neural
circuits in voluntary motor control (substantia nigra),
reward response (ventral tegmental area), transmission of
auditory and visual information (inferior and superior
colliculi), and regulation of sleep–wake stages (reticular
formation)1. Because multiple types of neurons reside in
the dorsal, medial, and ventral domains of the midbrain,
including glutamatergic, γ-amino butyric acid (GABA)
ergic, and dopaminergic (DA) neurons2, malformation or
functional impairment of midbrain neurons causes
abnormal somatosensory information processing3,4,
reward responses5, and sleep control6, as well as neuro-
logical disorders such as Parkinson’s disease7. Given the
important roles in normal brain function and the diver-
sity, the mechanisms of development and differentiation
of midbrain-speciﬁc neurons from stem cells have been of
great interest for decades8.
Wnt signal is one of the key regulatory pathways that
determine the regional identities of neural cells in devel-
oping embryos9,10, particularly those involved in
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specifying neural cells with posterior characteristics and
implicated in midbrain morphogenesis11. Deleting Wnt1
resulted in the loss of the mid-hindbrain junction and
failure in the midbrain and rostral hindbrain
formation12–14. In contrast, inhibiting Wnt signal by
endogenous inhibitors (Dickkopf homolog-1 [Dkk-1] and
Cerberus) was shown to specify forebrain regions in
vertebrates15,16. Moreover, Wnt ligands, depending on
their concentration gradients, can either induce the
expression of markers for posterior portions of the brain
including engrailed 1 (En1), a midbrain marker17, and
gastrulation brain homeodomain 2 (Gbx2), a hindbrain
marker18, or suppress that of forebrain markers in
explants of early avian embryos, suggesting that Wnt acts
as a critical posteriorizing factor in vertebrates11. The
hypothesis that similar developmental programs can be
applied to the human system has been supported by
recent differentiation studies using human pluripotent
stem cells (PSCs) such as embryonic stem cells (ESCs) and
induced pluripotent stem cells (iPSCs) in which the
endogenous level of the Wnt signal determined the
regional identity along the anteroposterior (AP) axis19;
moreover, stimulating Wnt signal could facilitate the
derivation of DA neurons that retain features of midbrain
origin20–22. It was known that DA neurons arise from the
ﬂoor plate of ventral midbrain, not of hindbrain23. Thus,
in attempts to induce authentic midbrain DA neurons,
ﬂoor plate speciﬁcation was ﬁrst accomplished by early
exposure of human PSCs to Sonic Hedgehog (SHH)24.
The differentiation strategy has been eventually evolved to
combined modulation of both Shh and Wnt signals20.
Despite all the implication of the Wnt signal in AP pat-
terning and midbrain speciﬁcation in both animal and
human systems, the detailed molecular mechanism
underlying how the Wnt signal drives posterior fate
during neural differentiation and how inhibitors of
glycogen synthase kinase 3 (GSK3), a key enzyme med-
iating the canonical Wnt signal, facilitate midbrain spe-
ciﬁcation during human stem cell differentiation
remained unclear.
Fibroblast growth factor 8 (FGF8) is secreted from the
isthmic organizer located in the mid-hindbrain junction
and thus composes a regulatory network for proliferation,
survival, and patterning in the midbrain region25,26. It also
acts as a key factor in inducing human PSCs into DA
progenitors in cooperation with SHH because its
expression in the developing embryonic brain is highly
correlated with the region in which midbrain DA neurons
arise27. A previous study supported this idea by providing
evidence that priming human ESC-derived neural pre-
cursor cells (NPCs) with FGF8 increased the number of
cells with a midbrain fate in the culture28. As such, the
molecular mechanism by which FGF8 contributes to fate
determination or regional identity of developing neural
cells in the midbrain area has been of interest in both
developmental and stem cell biology.
Here we explored the role of canonical Wnt signal in AP
patterning during neural differentiation of human PSCs.
In particular, we investigated the molecular events during
midbrain speciﬁcation by Wnt activation while char-
acterizing the interaction between the β-catenin/T-cell
factor (TCF) complex and the EN1 promoter region and
exploring the potential role of FGF8 in the same devel-
opmental context. Lastly, we examined the differentiation
potential of NPCs with a midbrain fate via small
molecule-based regulation of the canonical Wnt signal
pathway.
Materials and methods
Human PSC culture and differentiation
We routinely cultured the undifferentiated human ESC
line WA09 (H9, p37-49, WiCell Inc., Madison, WI, USA),
retrovirus-derived iPSCs (iPS-WT3)29, and episomal
vector-derived iPSCs (iPS-Epi3)30, and obtained the
homogenous population of NPCs from them through
modiﬁed dual SMAD inhibition and neural rosette
selection as described previously31. The NPCs were used
as a cellular platform to test the effects of Wnt signal on
regional speciﬁcation. Small molecules including 0.1–2
μM of 6-bromoindirubin-3ʹ-oxime (BIO; Sigma-Aldrich,
St. Louis, MO, USA), 10 μM of 1-azakenpaullone (1-AKP;
Sigma-Aldrich), and 5mM lithium chloride (LiCl; Sigma-
Aldrich) were used to modulate Wnt signal. We used
100 ng/ml FGF8b (PeproTech, Rocky Hill, NJ, USA) as a
control agent for midbrain speciﬁcation28. To further
differentiate NPCs into neurons, we mechanically
detached the cell clumps and plated them after mild tri-
turation on plates coated with Matrigel (Corning, Corn-
ing, NY, USA) and then cultured them in differentiation
medium composed of DMEM/F12 supplemented with N2
(1×; Invitrogen, Carlsbad, CA, USA), B27 supplement (1×;
Invitrogen), and various factors including 20 ng/ml glial
cell line-derived neurotrophic factor, 20 ng/ml brain-
derived neurotrophic factor, 2 ng/ml transforming growth
factor β (TGFβ) 3 (all from PeproTech), 200 μM ascorbic
acid, and 5 μM forskolin (Sigma-Aldrich). In some
experiments, we exposed NPCs to 200 ng/ml recombinant
human SHH CIl24 (R&D Systems, Minneapolis, MN,
USA) and 100 ng/ml of FGF8b for a week before neuronal
maturation.
Semi-quantitative and quantitative (real-time) RT-PCR
analyses
We performed RT-PCR and quantitative RT-PCR
(qRT-PCR) as described previously31; the primer
sequences are listed in Supplementary Table 1. Brieﬂy, we
extracted total RNA using an Easy-Spin® Total RNA
Puriﬁcation Kit (iNtRON Biotechnology, Seoul, Korea),
Kim et al. Experimental & Molecular Medicine (2018) 50:24 Page 2 of 13
Ofﬁcial journal of the Korean Society for Biochemistry and Molecular Biology
and then converted 1 µg of RNA into cDNA with the
iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA,
USA). QRT-PCR was performed using SYBR® Premix
ExTaq™ (TAKARA BIO Inc., Otsu, Japan) and the CFX96
Real-Time System (Bio-Rad). Beta-actin was used as an
endogenous reference to calculate Ct values and relative
expression levels (2−ΔΔCt) of target genes. For semi-qRT-
PCR, we performed PCR with the 2× EmeraldAmp® GT
PCR Master Mix (TAKARA BIO Inc.) and 10 pmol of
each primer (Supplementary Table 1). Ampliﬁed tran-
scripts were normalized to the glyceraldehyde 3-
phosphate dehydrogenase (GAPDH)-speciﬁc signal.
Lentiviral production for small hairpin RNA (shRNA)
For the β-catenin knockdown experiment, we obtained
two shRNA sequences from Addgene (Plasmid #18803:
pLKO.1 puro shRNA; #19761: pLKO.1.sh.β-catenin.1248;
Cambridge, MA, USA). We constructed scrambled
shRNA control using the HuSH™ shRNA plasmid pGFP-
C-shLent vector (OriGene, Rockville, MD, USA) and
produced the viruses by transient transfection of
293T cells with lentiviral packaging plasmids (pLP1, pLP2,
and pLP/VSVG; Invitrogen). We determined virus con-
centration using a Lenti-X Concentrator (Clontech,
Mountain View, CA, USA) following the manufacturer’s
protocol, and we monitored knockdown efﬁciency by
qRT-PCR and immunoblotting against β-catenin (see
below).
Immunocytochemistry
Cells were ﬁxed with 4% paraformaldehyde in
phosphate-buffered saline (PBS) for 30min, washed with
PBS, and perforated with PBS containing 0.1% Triton X-
100 for 10 min. Then, the samples were incubated with
blocking buffer (PBS containing 2% bovine serum albu-
min) for 1 h. The cells were incubated with primary
antibodies diluted in blocking buffer at 4 °C overnight.
The following primary antibodies were used: rabbit anti-
Nestin (1:1000, Millipore, Billerica, MA, USA), mouse
anti-β-catenin (1:1000, Santa Cruz Biotechnology, Dallas,
TX, USA), goat anti-SOX1 (1:100, R&D Systems), mouse
anti-EN1 (1:50, DSHB, Iowa City, IA, USA), rabbit anti-
TUJ1 (1:1000, Covance, Richmond, CA, USA), goat anti-
OTX2 (1:300, R&D systems), sheep anti-TH (1:300, Pel-
Freez, Rogers, AR, USA), rabbit anti-TH (1:300, Pel-
Freez), rabbit anti-glutamate (1:200, Sigma-Aldrich),
rabbit anti-GABA (1:2500, Sigma-Aldrich), goat anti-
LMX1A (1:200, Santa Cruz), rabbit anti-FOXA2 (1:300,
Millipore), mouse anti-synaptophysin (1:1000, Millipore),
and rabbit anti-MAP2 (1:500, Millipore). The samples
were washed three times with PBS and then incubated
with ﬂuorescence-tagged secondary antibodies (Alexa
Fluor 350, Alexa Fluor 488, and Alexa Fluor 594, 1:500,
Invitrogen) in blocking buffer for 30min at room
temperature. The cover slips were rinsed three times with
PBS and mounted onto slides using mounting medium
(Vector Laboratories, Burlingame, CA, USA). All images
were obtained using a ﬂuorescence microscope (DP71,
FSX100; Olympus, Tokyo, Japan) or an LSM700 confocal
microscope (Carl Zeiss, Oberkochen, Baden-Württem-
berg, Germany).
Immunoblotting
Cells were washed once with ice-chilled PBS and lysed
in a RIPA buffer (Sigma-Aldrich) with a protease inhibitor
cocktail (Roche Applied Science, Mannheim, Baden-
Württemberg, Germany). Protein was quantiﬁed using
the Bradford protein solution (Bio-Rad), and then 20 μg of
protein samples were separated on a 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred to a PVDF membrane (Millipore). After
incubation with 5% non-fat milk in Tris-buffered saline
containing 0.1% Tween 20 (TBS-T) for 1 h at room
temperature, the membrane was incubated with primary
antibodies (mouse anti-β-catenin (Santa Cruz Bio-
technology), mouse anti-EN1 (Abcam, Cambridge, UK),
and mouse anti-β-actin (Sigma-Aldrich)) for 1 h at room
temperature or overnight at 4 °C. The membrane was
washed three times with TBS-T and then incubated in a
1:3000 dilution of horseradish peroxidase-conjugated
anti-mouse secondary antibody for 30min at room tem-
perature. The membranes were washed with TBS-T three
times and developed with the enhanced chemi-
luminescence system (Pierce, Rockford, IL, USA)
according to the manufacturer’s protocols.
Co-immunoprecipitation (Co-IP) assay
Total cell lysates were prepared by NETN lysis buffer
(100 mM NaCl, 20 mM Tris-Cl, 0.5 mM EDTA, and 0.5%
(v/v) NP-40) with a protease inhibitor cocktail (Roche
Applied Science). Total protein was obtained from cell
lysates by centrifugation at 12,000×g for 30 min at 4 °C
and quantiﬁed using the Bradford protein solution (Bio-
Rad). The protein samples were incubated with a mouse
anti-TCF-4 antibody (Upstate, Billerica, MA, USA) over-
night at 4 °C and then incubated with protein G-
Sepharose beads (GE Healthcare Bio-Sciences, Pitts-
burgh, PA, USA) for 1 h at 4 °C with rotation. The beads
were collected by centrifugation, washed three times with
the same lysis buffer, dissolved in sample buffer, and
analyzed by SDS-PAGE followed by detection with mouse
anti-β-catenin antibody (Santa Cruz Biotechnology).
Chromatin immunoprecipitation (ChIP) assay
For ChIP assays, cells were cultured with BIO for 3 days,
at which point the cells were ﬁxed in formaldehyde for 10
min, and then 0.125M glycine was added to stop the
reaction. The cells were washed twice with PBS. The ChIP
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assays were performed with a ChIP kit (R&D Systems)
according to the manufacturer’s instructions. Brieﬂy, the
ﬁxed cells were lysed and sonicated to shear the genomic
DNA into 200–500 bp fragments. The cross-linked com-
plexes (DNA–protein) were immunoprecipitated with
anti-TCF4 antibody (Millipore) or normal goat IgG (Santa
Cruz). ChIP-enriched DNA was quantiﬁed by qRT-PCR
with primer pairs designed to ﬂank the putative TCF-
binding element. The primer sequences are listed in
Supplementary Table 2.
Plasmid and reporter gene constructs
Expression vectors for Flag-tagged constitutively active
β-catenin (β-catenin 4A; S33A, S37A, T41A, and S45A)
and Myc-tagged wild-type TCF-4 were obtained from
Addgene (plasmids #24204 and #16514). The human EN1
promoter fragment (−4961 ~−81) was ampliﬁed by PCR
using ExTaq (TAKARA BIO Inc.) and human dermal
ﬁbroblast’s genomic DNA as a template, and was sub-
cloned into the pGL3-basic Luciferase Reporter Vector
(Invitrogen). Cloning was performed using an In-fusion®
HD Cloning Kit (Clontech Laboratories Inc., Mountain
View, CA, USA). The primers were generated using
SnapGene® software and are listed in Supplementary
Table 3. The sequence of the EN1 promoter was aligned
with the sequence of human EN1 (engrailed homeobox 1)
on chromosome 2 (NCBI, NG_007123).
Transfection and luciferase reporter assays
For reporter assays, HEK 293 cells or NPCs were seeded
into a 12-well culture plate and transiently transfected
with 0.1 μg reporter plasmid and 30 ng pRL-SV40 plasmid
(Promega, Madison, WI, USA) containing the Renilla
luciferase gene under the control of the Simian virus 40
promoter using polyethyleneimine (PEI, Sigma-Aldrich).
For the over-expression of β-catenin and TCF4, cells were
transfected with plasmid using PEI. Forty-eight hours
after transfection, the cells were harvested, and luciferase
activity was measured and normalized to Renilla lucifer-
ase activity. The amount of DNA in each transfection was
kept constant by adding an appropriate amount of empty
vector.
Electrophysiological recording
Electrophysiological recording of the differentiated
neurons was conducted by whole-cell patch-clamp tech-
nique with an EPC 10 USB ampliﬁer (HEKA Electronik,
Lamprecht, Germany). The differentiated neurons
attached on the glass cover slips were transferred to a 0.5-
ml recording chamber that was superfused continuously
with a normal Tyrode solution by gravity at a rate of
approximately 10 ml/min. The recording electrodes were
manufactured from borosilicate glass capillaries (Sutter
Instrument Company, Novato, CA, USA) using a PC-10
puller (Narishige Co., Tokyo, Japan), and the resistance of
the pipettes was 4–6MΩ when ﬁlled with the pipette
solution described below. The cell membrane capacitance
and series resistance were electronically compensated
(typically 80%). After a giga-seal was obtained by negative
suction, the cell membrane was ruptured by gentle suc-
tion to establish a whole-cell conﬁguration. Data were
ﬁltered at 3 kHz, digitized at 10 kHz, and analyzed using
Pulse ver. 8.67 (HEKA Electronik) and Origin 6.1 software
(MicroCal, Northampton, MA, USA). All experiments
were performed at room temperature (21–24 °C). The
membrane potentials and currents were recorded with the
following normal Tyrode solution: 143 mM NaCl, 5.4 mM
KCl, 0.5 mM MgCl2, 1.8 mM CaCl2, 0.5 mM NaHPO4, 10
mM glucose, and 5mM HEPES. The pH level was
adjusted to 7.4 with NaOH. The pipette solution con-
tained 150mM KCl, 1.0 mM MgCl2, 10 mM HEPES, 5
mM EGTA, and 2 mM Mg-ATP, and the pH level was
adjusted to 7.2 with NaOH.
Statistics
Values are expressed as the mean ± S.E.M unless indi-
cated otherwise. We used ANOVA and Student’s t test
using SPSS software version 12.0 to determine the sta-
tistical signiﬁcance.
Results
Activating the canonical Wnt pathway induces midbrain-
speciﬁc gene expression in human PSC-NPCs
To obtain a cellular platform for investigating the role of
Wnt signal in AP patterning, we generated a NPC
population from human PSCs through the simultaneous
inhibition of the bone morphogenetic protein and TGFβ
signals with small molecules (dorsomorphin and
SB431542)31. We observed extensive neural rosette for-
mation in the center of the colonies 4–5 days after
attachment of embryoid bodies that were exposed to
dorsomorphin and SB431542 for 4 days (Fig. 1a).
Mechanically isolated neural rosettes were highly positive
for SOX1 and Nestin and maintained the typical mor-
phology of the neural rosette during expansion (Fig. 1b, c).
Because neural rosettes are an NPC population that can
respond to extrinsic patterning cues directing regional
speciﬁcation32,33, we used these cells to investigate cel-
lular events during AP patterning by modulating Wnt
signal pathway.
To test the potential effect of Wnt signal activation on
AP patterning, we ﬁrst treated human ESC-derived NPCs
with a small-molecule GSK3 inhibitor, BIO, which is
known to activate the canonical Wnt signal pathway34,35,
and then examined the expression of the following
representative AP markers by qRT-PCR: brain factor 1
(BF1, a forebrain marker36 also known as FOXG1), EN1,
and GBX2. As a positive control culture condition, we
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treated some cells with 100 ng/ml FGF8 because it was
shown to induce midbrain-fated NPCs when treated at
early stage of NPCs28. Once treated with BIO, NPCs
proliferated and formed compact colonies while
maintaining the expression of the NPC markers (Fig. 1d,
e). Quantitative gene expression analysis following seven
days of treatment revealed that EN1 expression increased
gradually in a dose-dependent manner up to ﬁve times at
Fig. 1 (See legend on next page.)
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1 μM, whereas the BF1 and GBX2 expression decreased as
the BIO concentration increased (Fig. 1f). Although the
EN1 expression was gradually upregulated as the BIO
concentration increased, detrimental effects on cell sur-
vival restricted us to use more than 2 μM BIO for sub-
sequent experiments (data not shown).
Immunoﬂuorescence staining supported the qRT-PCR
results by showing an evident increase in the number
EN1-positive cells in the BIO-treated group compared
with the non-treated control (Fig. 1g). Interestingly, BIO
treatment appeared to be more speciﬁc for inducing the
midbrain marker than FGF8 treatment. The treatment
with 1 μM BIO increased EN1 expression by two folds
compared to 100 ng/ml FGF8 treatment which instead
increased the level of GBX2 transcripts with no change of
BF1 expression (Fig. 1h). Upregulation of both EN1 and
GBX2 by FGF8 treatment might result from the fact that
FGF8 affects the speciﬁcation of both the midbrain and
hindbrain25. It was also intriguing that BF1 expression
was not affected by FGF8 treatment contradicting to the
previous result28 (Fig. 1h). The presence of SOX1-positive
cells in the neural rosettes (Fig. 1b) and the previous
ﬁnding that FGF8 suppresses the forebrain fate only in the
“primitive” NPCs (paired box protein 6 [PAX6]-positive,
but SOX1-negative)28, indicate that a substantial number
of the NPCs in our experiment are likely in the “deﬁnitive”
(i.e., PAX6/SOX1-double positive) stage and thus less
responsive to the activity of FGF8 in suppressing the
forebrain fate. Nonetheless, BIO treatment potently
increased EN1 expression. This result suggests that BIO is
a strong regionalizing cue and that our system stands
valid to examine the effect of such regionalizing cue and
its molecular mechanism.
Additional quantitative gene expression analysis with
other AP markers, such as SIX homeobox 3 (SIX3; fore-
brain37), paired box gene 2 (PAX2; midbrain38), and
homeobox protein HOXA2 (hindbrain39), yielded similar
results (Fig. 1i), supporting the midbrain-speciﬁc regio-
nalization of human ESC-derived NPCs following BIO
treatment. We also observed the same AP marker
expression patterns after BIO treatment on both NPCs
derived from two iPSC lines (iPS-WT3 and Epi3; Sup-
plementary Fig. 1A-B and data not shown) and human
ESC-derived NPCs cultured in suspension as described
previously31 (Supplementary Fig. 1C), suggesting the
robust effect of BIO on midbrain speciﬁcation regardless
of human PSC type or cultivation method.
To conﬁrm whether the effect of BIO on midbrain
speciﬁcation was indeed through the activation of cano-
nical Wnt signal, we tested other small molecules that
inhibit GSK3 in different modes of action, such as 1-
AKP40 and LiCl41,42. Exposing human ESC-derived NPCs
to 1-AKP robustly increased EN1 expression, whereas BF1
expression level strongly decreased (Fig. 1j). LiCl treat-
ment elicited similar gene expression patterns, although
the fold changes in gene expression were lower than those
of the other inhibitors (Fig. 1k). These data support that
midbrain-speciﬁc gene expression results from the acti-
vation of canonical Wnt signal via GSK3 inhibition43,44.
As another approach to investigate the involvement of
the canonical Wnt signal pathway in the midbrain spe-
ciﬁcation, we inhibited endogenous Wnt signal in the
NPC culture and examined the EN1 expression level.
When the NPCs were cultured in the presence of Wnt
signal antagonists such as DKK-1 or frizzled5-Fc (FZD-5),
basal EN1 expression was found to be signiﬁcantly lower
in both cases (Fig. 1l); signiﬁcant diminution of EN1
expression by FZD-5 was also found in iPSC-derived
NPCs (Supplementary Fig. 2). Furthermore, knockdown
of β-catenin by transducing NPCs with speciﬁc shRNAs
downregulated EN1 protein level as well as β-catenin
(Fig. 1m). Taken together, our results strongly suggest
that the canonical Wnt signal pathway directly con-
tributes to the expression of midbrain-speciﬁc genes in
human PSC-derived NPCs.
The β-catenin/TCF complex binds directly to the EN1
promoter region
Previous genetic studies in Xenopus and mice provided
evidence that ablation of Wnt1 disrupts the AP axis, and
that Wnt1 regulates EN1 expression in the earliest
stages12,45–47. These ﬁndings prompted us to ask whether
(see ﬁgure on previous page)
Fig. 1 Activation of Wnt signal induces midbrain characteristics in human ESC-derived NPCs. a Efﬁcient induction of neural rosette cells from
human ESCs by co-treatment with dorsomorphin and SB431542. b Strong immunoreactivity for SOX1 and Nestin in neural rosette cells. Morphology
of neural rosette cells expanding in either the absence (c) or the presence of 1 μM BIO (d). e NPCs treated with BIO maintained immunoreactivity for
SOX1 and Nestin. f Treatment with BIO upregulated EN1 expression and downregulated expressions of BF1 and GBX2 in dose-dependent manner. g
BIO treatment signiﬁcantly increased the number of EN1-positive neural cells. h The inductive effect of BIO treatment on midbrain fate appeared to
be more speciﬁc than that of FGF8. i Expression pattern of another set of regional markers (SIX3 for forebrain; PAX2 for midbrain; and HOXA2 for
hindbrain) supported the midbrain-biased fate of NPCs treated with BIO. Treatment with other known GSK3 inhibitors, 1-AKP (j) and LiCl (k), resulted
in regionalization comparable to BIO treatment. l Treating NPCs with Wnt antagonists (100 ng/ml DKK-1 and 500 ng/ml frizzled-5) downregulated the
endogenous level of EN1 transcript in NPCs. m Immunoblot for β-catenin and EN1 protein after introduction of two different β-catenin-speciﬁc
shRNAs (shRNA-1 and shRNA-2). EN1 protein level was directly downregulated by β-catenin knockdown. β-actin was a loading control. All data are
expressed as mean ± S.E.M. Statistical signiﬁcance was estimated using Student’s t test (g, i, j, and k) or one-way ANOVA (f, h, and l) from at least three
independent experiments; *p < 0.05, **p < 0.01. Scale bar: 200 μm for a, c, and d; 50 μm for b, e, and g
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EN1 expression is directly regulated through binding of
transcriptional modulators, downstream of the canonical
Wnt signal, to its regulatory DNA elements in the human
system. First, we veriﬁed that the interaction between β-
catenin and TCF4, a well-known interacting partner of
nuclear β-catenin, was increased by BIO treatment in
human ESC-derived NPCs on Co-IP assay (Fig. 2a)
We next sought to determine the regulatory element
around the EN1 gene locus for the β-catenin/TCF com-
plex binding. Because β-catenin lacks DNA-binding
motifs, we searched putative binding sites for TCF4
using Patch 1.0 Transfac®. We identiﬁed eight candidates
localized within a 5-kb region upstream of the human
EN1 transcription start site (Supplementary Fig. 3A, sites
1–8), but only one (site 6) out of the eight putative
binding motifs was conﬁrmed to be the consensus
sequence for TCF4 (Supplementary Fig. 3B). To deter-
mine whether the β-catenin/TCF4 complex binds to the
putative binding motif in response to the activation of the
Wnt signal, we performed a ChIP assay using an antibody
speciﬁc for β-catenin after treatment with BIO. In result,
the β-catenin/TCF4 complex binding to site 6 was
markedly induced after BIO treatment in human ESC-
derived NPCs, whereas binding to other sites with non-
consensus sequences (site 4, for example) did not take
place signiﬁcantly (Fig. 2b). Interestingly, β-catenin/TCF4
complex binding to site 6 also increased markedly with
BIO treatment in human ESCs (Fig. 2b). Our result
demonstrates that β-catenin/TCF4 complex binding not
only appears to increase with neural differentiation (ESC
vs. NPC in Fig. 2b), but also increases in response to Wnt
activation (NPC vs. NPC+ BIO in Fig. 2b). These results
suggest that the accessibility of regulatory elements situ-
ated in EN1 gene depends on developmental stage as well
as the recruitment of β-catenin/TCF4 complex to its
regulatory element via Wnt activation.
In order to further examine whether the β-catenin/
TCF4 complex directly induces EN1 transcription, we
performed the promoter activity assay using an EN1
promoter-luciferase reporter plasmid in HEK 293 cells. A
constitutively active mutant of β-catenin (Cat4A), wild-
type (WT)-TCF4, and dominant-negative (DN)-TCF4
expression plasmid were transfected either alone or in
combination and then the luciferase activity was
Fig. 2 EN1 expression is regulated by the β-catenin/TCF complex through direct binding to the EN1 promoter region. a Co-IP analysis
showed that the interaction between β-catenin and TCF4 increased by BIO-treatment. b, c ChIP assays for β-catenin/TCF4 complex to the putative
binding motif of EN1 promoter. The y-axis represents the means ± S.E.M. of the relative binding level of β-catenin (via TCF4) to each target sequence.
c Expression of luciferase driven by a 5-kb-long regulatory region of human EN1 gene in HEK 293 cells. A reporter gene was strongly induced by over-
expression of both constitutively active mutant of β-catenin (Cat4A) and WT-TCF4. d BIO treatment directly increased luciferase expression under the
control of the EN1 regulatory sequence in human ESC-derived NPCs. Statistical signiﬁcance was estimated using one-way ANOVA with multiple
comparisons among groups from at least three independent experiments; * p < 0.05, ** p < 0.01.
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measured. Surprisingly, co-transfection of the Cat4A and
WT-TCF4 dramatically increased transcriptional activity
compared with transfection of the Cat4A or WT-TCF4
alone (Fig. 2c). In addition, we observed no transcriptional
activity when we co-introduced Cat4A with DN-TCF4
(Fig. 2c). These ﬁndings indicate that β-catenin and TCF4
bind to the EN1 promoter and induce the transcription as
a complex. Finally, when the EN1 promoter activity was
tested in human ESC-derived NPCs, BIO treatment
indeed slightly but signiﬁcantly upregulated luciferase
activity compared with the non-treated control group
(Fig. 2d). Collectively, our data demonstrate that activat-
ing the canonical Wnt pathway induces EN1 expression
through direct binding of β-catenin/TCF to the EN1
promoter region in human ESC-derived NPCs.
FGF signal is required for the induction of EN1 by Wnt
signal activation
Previous evidence demonstrating the involvement of
FGF signal in AP patterning and in inducing midbrain and
rostral hindbrain cells9,26,46–49 prompted us to further
investigate the role of FGF signal in midbrain speciﬁcation
by Wnt activation. As shown in Fig. 3a, we detected the
endogenous expression of various FGF transcripts in the
NPC culture. We also found that treatment of GSK3
inhibitor increased the expression of FGF8 as well as
functionally related FGFs (FGF17, 18) (Fig. 3a), which is
consistent with the previous ﬁndings in rodents that FGF8
expression is induced by the activation of the Wnt signal
in the midbrain9,46,47. To determine whether an endo-
genous FGF signal is required for basal EN1 expression,
we treated human ESC-derived NPCs with 2.5 μM
SU5402, an FGF receptor tyrosine kinase inhibitor, for
5 days. Gene expression analysis showed that blocking
endogenous FGF signal signiﬁcantly reduced EN1
expression (Fig. 3b), indicating that endogenous FGF
signal is at least partially responsible for the basal
expression of EN1. To further examine the involvement of
FGF signal in induction of EN1 expression by Wnt acti-
vation, we treated NPCs with either recombinant FGF8 or
SU5402 in the presence of BIO. After 5 days of treatment,
qRT-PCR analysis revealed that co-treatment with FGF8
and BIO upregulated EN1 expression more than treat-
ment with BIO alone, but the increment did not reach
statistical signiﬁcance (Fig. 3c). However, when FGF signal
is blocked by treatment with SU5402 in the presence of
BIO, the increased EN1 expression, attributed to endo-
genous plus BIO-induced FGFs, was abrogated (Fig. 3c).
Immunoblot analysis showed a similar pattern of EN1
protein level to the results from qRT-PCR (Fig. 3d, e).
Intriguingly, the total protein levels of β-catenin increased
signiﬁcantly in all BIO-treated groups compared with the
untreated control but were unaffected by the presence of
FGF8 or SU5402 (Fig. 3d, e). A recent study showed that
FGF receptor tyrosine kinase directly phosphorylates β-
catenin at Tyr142 upon FGF binding, liberating β-catenin
from the membrane and allowing for transcriptional
activation in the nucleus50. This result prompted us to
examine whether FGF signal would inﬂuence on the
subcellular localization of β-catenin under the active Wnt
signal. Immunocytochemical analysis of β-catenin showed
that β-catenin immunoreactivity was localized in the
plasma membrane in the control group, but BIO treat-
ment remarkably localized β-catenin in the nuclei (Fig. 3f,
g). Moreover, FGF signal was unlikely to affect its trans-
location to the nucleus by Wnt activation (the BIO group
vs. the BIO+ FGF8 or BIO+ SU groups in Fig. 3f, g).
Taken together, our data suggest that FGF signal posi-
tively inﬂuences EN1 expression in human ESC-derived
NPCs but in a manner independent of the nuclear
translocation of β-catenin.
Differentiation potential of midbrain NPCs induced by BIO
treatment
Next, we explored the differentiation potential of the
midbrain-fated NPCs. After 1 week of BIO treatment, we
differentiated the NPCs under neuronal maturation con-
ditions (see Materials and Methods). After 3 weeks of
neuronal differentiation, immunocytochemical analysis
showed that 62.3 ± 3.4% of the total cells were positive for
TUJ1 in the BIO-treated group, whereas 33.9 ± 6.1% of the
cells turned positive for TUJ1 in the control group
(Fig. 4a), possibly attributed to Wnt promoted neuro-
genesis51. As we expected, BIO-treated NPCs generated
more TUJ1-positive neuronal cells that co-expressed EN1
(67.6 ± 6.6%) than the control group (10.6 ± 12.7%, p <
0.05; Fig. 4b). Notably, the majority of EN1-positive cells
in BIO-treated group was also positive for orthodenticle
homeobox 2 (OTX2) (70.6 ± 10.0%; Fig. 4b). Given that
dual immunoreactivity of EN1 and OTX2 is indicative of
midbrain fate,11,21 the majority of neurons expressing EN1
was indeed of midbrain character. Interestingly, glutamate
(Glu)-positive putative excitatory neurons were the
majority (58.7 ± 6.7%) among EN1-positive cells followed
by GABA-positive (16.7 ± 5.3%) and TH-positive cells
(10.2 ± 2.8%) (Fig. 4c). Considering the fact that gluta-
matergic excitatory and GABAergic inhibitory neurons
mainly arise within the dorso-medial region whereas DA
neurons are born in the most ventral region in the mid-
brain52, BIO treatment appeared to drive NPCs toward
dorso-medial midbrain fates. To further explore whether
the NPCs treated with BIO could also potentially generate
neurons of the ventral midbrain (e.g., DA neurons), we
treated NPCs with 200 ng/ml SHH and 100 ng/ml FGF8
for a week following BIO treatment. Immunostaining
followed by quantitative analysis revealed that the treat-
ment with SHH and FGF8 increased the proportion of
TH-positive cells among EN1-positive cells (20.9 ± 2.8%)
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while signiﬁcantly decreasing the proportion of Glu-
positive or GABA-positive cells (4.8 ± 3.0% and 2.9 ± 0.8%,
respectively) (Fig. 4d vs. Fig. 4c). Intriguingly, further
characterization of the TH-positive cells revealed that
they rarely co-expressed LIM homeobox transcription
factor 1 alpha (LMX1A), a determinant gene for midbrain
DA neurons53, or forkhead box protein A2 (FOXA2), a
ﬂoor plate marker23 (Fig. 4e, f, left). This result could be
attributed to the fact that authentic midbrain DA neurons
originate from the ﬂoor plate of the midbrain23 and the
speciﬁcation of ﬂoor plate fate is only efﬁcient when
human PSCs are exposed to an active form of SHH from
the early stage of differentiation. Consistently, when we
differentiated human ESCs using a previous method based
on ﬂoor plate differentiation20, most of the TH-positive
cells strongly co-expressed LMX1A and/or FOXA2
Fig. 3 FGF signal is required for induction of EN1 by activation of Wnt signal. a Semi-qRT-PCR analysis showed endogenous and BIO-induced
expression of various FGFs in human ESC-derived NPCs. b Inhibition of endogenous FGF signals by SU5402 signiﬁcantly decreased basal EN1
expression. c Co-treatment with BIO and FGF8 slightly increased EN1 expression more than BIO alone whereas co-treatment of SU5402 with BIO
abrogated the upregulation of EN1 expression (n= 4). d, e Immunoblotting corresponded with the EN1 expression in qRT-PCR (n= 3). f, g Nucleus
localization of β-catenin was induced by Wnt activation, but not affected by FGF. White arrows indicate β-catenin in nucleus (scale bar: 20 μm, n= 3).
Statistical signiﬁcance was examined by one-way ANOVA; ††p= 0.001, *p < 0.05
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Fig. 4 Generation of functional midbrain neurons from the NPCs pre-exposed to BIO. a, b NPCs treated with BIO gave rise to TUJ1-positive and
TUJ1/EN1 double-positive cells more than non-treated control NPCs. Note that the majority of EN1-positive neurons in BIO-treated group co-
expressed OTX2 (b). c NPCs treated with BIO differentiated into various neuronal subtypes, primarily Glu-positive cells followed by GABA-positive and
TH-positive cells. d The proportion of neuronal subtype cells differentiated by treatment with SHH and FGF8 following BIO. TH-positive cells were the
most abundant, followed by GABA-positive and Glu-positive cells. e, f TH-positive cells generated by sequential treatment of BIO and SHH+ FGF8
rarely co-expressed LMX1A or FOXA2 whereas TH-positive cells differentiated by ﬂoor plate-based protocol20 were highly positive for both markers.
g–i Neurons derived from NPCs treated with BIO were functional, as exempliﬁed by the immunoreactivity of synaptophysin on dendrites (indicated
by white arrows; g) and voltage-dependent membrane currents (bottom traces; h), depolarizing voltage steps (top traces; h) as well as evoked action
potential by current injection (i). Bars in the graphs are presented as mean ± standard deviation. Statistical signiﬁcance was determined by Student’s t
test; *p < 0.05. Scale bars: 20 μm
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(Fig. 4e, f, right). Thus, few TH-positive cells co-
expressing LMX1A or FOXA2 might be resulted from
an inefﬁcient ventralization of NPCs because SHH was
treated at a later stage (after BIO treatment) in our dif-
ferentiation conditions.
Lastly, we assessed the functionality of neurons after the
3-week differentiation. As shown in Fig. 4g, microtubule-
associated protein 2 (MAP2)-positive signals were co-
localized with the immunoreactivity of synaptophysin on
their dendrites or cell bodies, which indicates that these
neurons have the potential to form synapses. We then
tested the excitable electrophysiological property of the
neurons. The resting membrane potential of the differ-
entiated neurons ranged from −57 to −65mV (−60.8 ±
1.1 mV, n= 8). The neurons exhibited voltage-dependent
membrane currents that were elicited by 100-ms voltage
steps between −80 and 20mV from a holding potential of
−60 mV (Fig. 4h, n= 8/11). Depolarizing voltage steps
elicited both large outward potassium currents and fast
inward sodium currents. In the current-clamp conﬁg-
uration, a short square current injection (3 ms) above the
supra-threshold induced action potential in the neurons,
and prolonged depolarizing current injections (500 ms)
caused the neurons to ﬁre a single action potential
(Fig. 4i). These results indicate that the differentiated cells
had characteristics of mature neurons.
Discussion
Wnt family proteins are expressed in the posterior
region of vertebrate embryos during gastrulation, and
accumulating evidence suggests Wnt signal as a specifying
agent in caudal neural characterization11,13. Previously, an
elegant study provided direct evidence that Wnt signal, in
combination with FGF signal, is responsible for inducing
posterior characteristics in the neural cells of gastrulating
chick embryos in a dose-dependent manner11. A later
report by the same group showed that cells with the
molecular and functional characteristics of the isthmic
organizer could be induced from naïve neural plate cells
by a combination of Wnt and FGF54.
In substantial agreement with ﬁndings from animal
models, our data demonstrate that the activation of the
canonical Wnt pathway by small-molecule GSK3 inhibi-
tors induces a midbrain-like gene expression proﬁle in
human ESC-derived NPCs49. Our data also show that
inhibition of the canonical Wnt pathway by either a Wnt
signal antagonist or β-catenin knockdown signiﬁcantly
reduces endogenous EN1 expression, supporting that the
canonical Wnt pathway is critical for the midbrain spe-
ciﬁcation of human ESC-derived NPCs. Our data also
recapitulate previous results from embryos of lower ver-
tebrates with human ESC-derived NPCs by showing that
(1) FGF signal is required for posteriorization by activa-
tion of Wnt signal in human ESC-derived NPCs55
(Fig. 3c–e), and that (2) the activation of canonical Wnt
signal by GSK3 inhibition elevates the expression of
FGF811,56 (Fig. 3a). These ﬁndings suggest that both sig-
nals cooperate in promoting midbrain-speciﬁc gene
expression in human ESC-derived NPCs11,55,56 and that
this cellular machinery is evolutionarily well preserved.
Although the detailed molecular mechanism of how Wnt
and FGF signals interact to induce EN1 expression in
human ESC-derived NPCs requires further study, our
data clearly show that FGFs are necessary for induction of
EN1, at least in a manner independent of the nuclear
translocation of β-catenin (Fig. 3f, g). Moreover, our work
provides molecular evidence that the β-catenin/TCF
complex directly interacts with regulatory element of the
EN1 gene in human ESC-derived NPCs. Most impor-
tantly, we identiﬁed a potential β-catenin/TCF complex-
binding site in the regulatory element of human EN1
gene. As hypothesized, GSK3 inhibition resulted the
enhanced binding of the β-catenin/TCF complex to the
putative sites, by which canonical Wnt signal can directly
increase the transcriptional level of EN1.
According to the recent studies from two independent
groups, activating Wnt signal by applying a different
GSK3 inhibitor, CHIR99021, during the neural differ-
entiation of human ESCs induces NPCs to a posterior fate
in a dose-dependent manner, and the strong activation of
Wnt signal even drives cells to a hindbrain fate21,22. In our
experiment, however, Wnt signal activation by treatment
with BIO (as well as with 1-AKP and lithium) only
increased the midbrain speciﬁc genes but did not induce
the hindbrain genes, even with higher dosage of BIO (>1
μM). One possible explanation for this discrepancy would
be the usage of the cells at different stages. Unlike the
previous studies in which Wnt activation started at the
initial stage of neural differentiation (day 0 ~ 3), we
examined the effect of Wnt activation with the neural
rosette cells, which is a much later stage than in previous
studies. As other studies suggest, NPCs in different
developmental stages exhibit variable responsiveness to
regional patterning cues57,58. Therefore, different tem-
poral windows for patterning as well as speciﬁc dosages of
the patterning cue may result in distinctive regional fates.
It is likely that applying patterning cues during early
stages of differentiation may be a better strategy if the
purpose is purely obtaining neural cells with a particular
fate at high efﬁciency.
It is interesting to note that NPCs treated with BIO
predominantly generated glutamatergic and GABAergic
neurons (Fig. 4c). In the mouse midbrain, glutamatergic
and GABAergic neurons are interspersed in the dorso-
ventral axis from the inferior and superior colliculi of the
dorsal midbrain to the ventral midbrain including the
substantia nigra and ventral tegmental area52,59. Both
subtypes found in various locations of the midbrain are
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highly heterogeneous in morphological and neurochem-
ical properties, and they participate in a variety of neural
pathways including relaying somatosensory information
and modulating voluntary movement3. Even though the
distribution of midbrain glutamatergic and GABAergic
neurons and the underlying molecular regulation in fate
determination of both types have begun to be understood
from mouse genetic studies, understanding the functional
diversity and detailed differentiation mechanisms of
human midbrain neurons is still on high demand owing to
their implications in various neurological and psycholo-
gical diseases52,59,60. In this regard, our differentiation
paradigm may provide an efﬁcient system for generating a
midbrain neuron model that can be used to study devel-
opmental mechanisms and roles in relevant neurological
disorders.
In conclusion, we demonstrated that the canonical Wnt
signal pathway regulates AP patterning during neural
differentiation in human PSCs. We show that activating
Wnt signal in human ESC-derived NPCs causes neural
cells to exhibit midbrain characteristics. More impor-
tantly, our data demonstrate that Wnt signal regulates
EN1 transcription through direct binding of the β-cate-
nin/TCF4 complex to the regulatory element of EN1
promoter. Collectively, our ﬁnding provides mechanistic
insights and technical advances in midbrain speciﬁcation
from human PSCs.
Acknowledgements
This research was supported by the Bio & Medical Technology Development
Program of the National Research Foundation (NRF) (2017M3A9B4042580), the
Basic Science Research Program of the NRF (2015R1D1A1A01056649) from the
Ministry of Science and ICT, the Korea Health Technology R&D Project from the
Ministry of Health & Welfare (HI15C0916), and Korea University Grants
(K1504121 and K1505391).
Author details
1Department of Physiology, Yonsei University College of Medicine, 50-1
Yonsei-ro Seodaemun-gu, Seoul 03722, Korea. 2Brain Korea 21 PLUS Program
for Medical Science, Yonsei University College of Medicine, 50-1 Yonsei-ro,
Seodaemun-gu, Seoul 03722, Korea. 3Department of Physiology, College of
Medicine, Hanyang University, 222 Wangsimni-ro, Seoul 04763, Korea.
4Department of Biotechnology, Brain Korea 21 PLUS program for
Biotechnology, College of Life Science & Biotechnology, Korea University, 145
Anam-ro, Seongbuk-gu, Seoul 02841, Korea
Author contributions
J.Y.K.: Data design, collection and/or assembly, analysis, and interpretation,
manuscript writing. J.S.L.: Data collection and/or assembly, analysis, and
interpretation. H.S.H., D.R.L., and C.-Y.P.: Data analysis and interpretation. S.J.J., Y.
R.Y.: Data collection and/or assembly, analysis. D.-S.K.: Conception and design,
data analysis and interpretation, ﬁnancial support, manuscript writing. D.-W.K.:
Conception and design, ﬁnancial support, data analysis and interpretation,
manuscript writing, ﬁnal manuscript approval.
Conﬂict of interest
The authors declare that they have no conﬂict of interest.
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Supplementary information accompanies this paper at https://doi.org/
10.1038/s12276-018-0044-y.
Received: 13 September 2017 Revised: 30 November 2017 Accepted: 19
December 2017.
Published online: 13 April 2018
References
1. Bissonette, G. B. & Roesch, M. R. Development and function of the midbrain
dopamine system: what we know and what we need to. Genes Brain Behav.
15, 62–73 (2006).
2. Morello, F. & Partanen, J. Diversity and development of local inhibitory and
excitatory neurons associated with dopaminergic nuclei. FEBS Lett. 589,
3693–3701 (2015).
3. Stein, B. E., Stanford, T. R. & Rowland, B. A. Development of multisensory
integration from the perspective of the individual neuron. Nat. Rev. Neurosci.
15, 520–535 (2014).
4. Hutchinson, M. et al. Cervical dystonia: a disorder of the midbrain network for
covert attentional orienting. Front. Neurol. 5, 54 (2014).
5. Volkow, N. D. & Morales, M. The brain on drugs: from reward to addiction. Cell
162, 712–25 (2015).
6. Chen, M. C., Yu, H., Huang, Z. L. & Lu, J. Rapid eye movement sleep behavior
disorder. Curr. Opin. Neurobiol. 23, 793–798 (2013).
7. Blaess, S. & Ang, S. L. Genetic control of midbrain dopaminergic neuron
development. Wiley Interdiscip. Rev. Dev. Biol. 4, 113–34 (2015).
8. Arenas, E., Denham, M. & Villaescusa, J. C. How to make a midbrain dopa-
minergic neuron. Development 14, 1918–1936 (2015).
9. Castelo-Branco, G. & Arenas, E. Function of Wnts in dopaminergic neuron
development. Neurodegener. Dis. 3, 5–11 (2006).
10. Alves dos Santos, M. T. & Smidt, M. P. En1 and Wnt signaling in midbrain
dopaminergic neuronal development. Neural Dev. 6, 23 (2011).
11. Nordström, U., Jessell, T. M. & Edlund, T. Progressive induction of caudal neural
character by graded Wnt signaling. Nat. Neurosci. 5, 525–532 (2002).
12. McMahon, A. P. & Bradley, A. The Wnt-1 (int-1) proto-oncogene is required for
development of a large region of the mouse brain. Cell 62, 1073–1085 (1990).
13. Thomas, K. R. & Capecchi, M. R. Targeted disruption of the murine int-1 proto-
oncogene resulting in severe abnormalities in midbrain and cerebellar
development. Nature 346, 847–850 (1990).
14. Danielian, P. S. & McMahon, A. P. Engrailed-1 as a target of the Wnt-1 sig-
nalling pathway in vertebrate midbrain development. Nature 383, 332–334
(1996).
15. Glinka, A. et al. Dickkopf-1 is a member of a new family of secreted proteins
and functions in head induction. Nature 391, 357–362 (1998).
16. Piccolo, S. et al. The head inducer Cerberus is a multifunctional antagonist of
Nodal, BMP and Wnt signals. Nature 397, 707–710 (1999).
17. Wurst, W., Auerbach, A. B. & Joyner, A. L. Multiple developmental defects in
Engrailed-1 mutant mice: an early mid-hindbrain deletion and patterning
defects in forelimbs and sternum. Development 120, 2065–2075 (1994).
18. Wassarman, K. M. et al. Speciﬁcation of the anterior hindbrain and establish-
ment of a normal mid/hindbrain organizer is dependent on Gbx2 gene
function. Development 124, 2923–2934 (1997).
19. Moya, N., Cutts, J., Gaasterland, T., Willert, K. & Brafman, D. A. Endogenous WNT
signaling regulates hPSC-derived neural progenitor cell heterogeneity and
speciﬁes their regional identity. Stem Cell Rep. 3, 1015–1028 (2014).
20. Kriks, S. et al. Dopamine neurons derived from human ES cells efﬁciently
engraft in animal models of Parkinson’s disease. Nature 480, 547–551 (2011).
21. Xi, J., Liu, Y., Liu, H., Chen, H., Emborg, M. E. & Zhang, S. C. Speciﬁcation of
midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells
30, 1655–1663 (2012).
22. Kirkeby, A. et al. Generation of regionally speciﬁed neural progenitors and
functional neurons from human embryonic stem cells under deﬁned condi-
tions. Cell Rep. 1, 703–714 (2012).
23. Joksimovic, M. et al. Wnt antagonism of Shh facilitates midbrain ﬂoor plate
neurogenesis. Nat. Neurosci. 12, 125–31 (2009).
24. Fasano, C. A., Chambers, S. M., Lee, G., Tomishima, M. J. & Studer, L. Efﬁcient
derivation of functional ﬂoor plate tissue from human embryonic stem cells.
Cell Stem Cell 6, 336–47 (2010).
25. Partanen, J. FGF signalling pathways in development of the midbrain and
anterior hindbrain. J. Neurochem. 101, 1185–1193 (2007).
Kim et al. Experimental & Molecular Medicine (2018) 50:24 Page 12 of 13
Ofﬁcial journal of the Korean Society for Biochemistry and Molecular Biology
26. Lahti, L., Peltopuro, P., Piepponen, T. P. & Partanen, J. Cell-autonomous FGF
signaling regulates anteroposterior patterning and neuronal differentiation in
the mesodiencephalic dopaminergic progenitor domain. Development 139,
894–905 (2012).
27. Ye, W., Shimamura, K., Rubenstein, J. L., Hynes, M. A. & Rosenthal, A. FGF and
Shh signals control dopaminergic and serotonergic cell fate in the anterior
neural plate. Cell 93, 755–766 (1998).
28. Yan, Y. et al. Directed differentiation of dopaminergic neuronal subtypes from
human embryonic stem cells. Stem Cells 23, 781–790 (2005).
29. Jang, J. et al. Disease-speciﬁc induced pluripotent stem cells: a platform for
human disease modeling and drug discovery. Exp. Mol. Med. 44, 202–213
(2012).
30. Park, C. Y. et al. Targeted inversion and reversion of the blood coagulation
factor 8 gene in human iPS cells using TALENs. Proc. Natl Acad. Sci. USA 111,
9253–9258 (2014).
31. Kim, D. S. et al. Robust enhancement of neural differentiation from human ES
and iPS cells regardless of their innate difference in differentiation propensity.
Stem Cell Rev. 6, 270–281 (2010).
32. Elkabetz, Y. et al. Human ES cell-derived neural rosettes reveal a functionally
distinct early neural stem cell stage. Genes Dev. 22, 152–165 (2008).
33. Gaspard, N. & Vanderhaeghen, P. Mechanisms of neural speciﬁcation from
embryonic stem cells. Curr. Opin. Neurobiol. 20, 37–43 (2010).
34. Meijer, L. et al. GSK-3-selective inhibitors derived from Tyrian purple indirubins.
Chem. Biol. 10, 1255–1266 (2003).
35. Sato, N., Meijer, L., Skaltsounis, L., Greengard, P. & Brivanlou, A. H. Maintenance
of pluripotency in human and mouse embryonic stem cells through activa-
tion of Wnt signaling by a pharmacological GSK-3-speciﬁc inhibitor. Nat. Med.
10, 55–63 (2004).
36. Murphy, D. B. et al. Human brain factor 1, a new member of the fork head
gene family. Genomics 21, 551–557 (1994).
37. Lagutin, O. V. et al. Six3 repression of Wnt signaling in the anterior neu-
roectoderm is essential for vertebrate forebrain development. Genes Dev. 17,
368–379 (2003).
38. Pfeffer, P. L., Payer, B., Reim, G., di Magliano, M. P. & Busslinger, M. The activation
and maintenance of Pax2 expression at the mid-hindbrain boundary is con-
trolled by separate enhancers. Development 129, 307–318 (2002).
39. Prince, V. E., Moens, C. B., Kimmel, C. B. & Ho, R. K. Zebraﬁsh hox genes:
expression in the hindbrain region of wild-type and mutants of the seg-
mentation gene, valentino. Development 125, 393–406 (1998).
40. Kunick, C., Lauenroth, K., Leost, M., Meijer, L. & Lemcke, T. 1-Azakenpaullone is a
selective inhibitor of glycogen synthase kinase-3 beta. Bioorg. Med. Chem. Lett.
14, 413–416 (2004).
41. Phiel, C. J. & Klein, P. S. Molecular targets of lithium action. Annu. Rev. Pha-
macol. Toxicol. 41, 789–813 (2011).
42. Zhang, F., Phiel, C. J., Spece, L., Gurvich, N. & Klein, P. S. Inhibitory phosphor-
ylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence
for autoregulation of GSK-3. J. Biol. Chem. 278, 33067–33077 (2003).
43. MacDonald, B. T., Tamai, K. & He, X. Wnt/beta-catenin signaling: components,
mechanisms, and diseases. Dev. Cell 17, 9–26 (2009).
44. Rao, T. P. & Küh, M. An updated overview on Wnt signaling pathways: a
prelude for more. Circ. Res. 106, 1798–806 (2010).
45. McMahon, A. P., Joyner, A. L., Bradley, A. & McMahon, J. A. The midbrain-
hindbrain phenotype of Wnt-1-/Wnt-1- mice results from stepwise deletion of
engrailed-expressing cells by 9.5 days postcoitum. Cell 69, 581–595 (1992).
46. McGrew, L. L., Otte, A. P. & Moon, R. T. Analysis of Xwnt-4 in embryos of
Xenopus laevis: a Wnt family member expressed in the brain and ﬂoor plate.
Development 115, 463–473 (1992).
47. Kiecker, C. & Niehrs, C. A morphogen gradient of Wnt/beta-catenin signalling
regulates anteroposterior neural patterning in Xenopus. Development 128,
4189–4201 (2001).
48. Muhr, J., Graziano, E., Wilson, S., Jessell, T. M. & Edlund, T. Convergent inductive
signals specify midbrain, hindbrain, and spinal cord identity in gastrula stage
chick embryos. Neuron 23, 689–702 (1999).
49. Liu, A. & Joyner, A. L. Early anterior/posterior patterning of the midbrain and
cerebellum. Annu. Rev. Neurosci. 24, 869–896 (2001).
50. Krejci, P. et al. Receptor tyrosine kinases activate canonical WNT/β-catenin
signaling via MAP kinase/LRP6 pathway and direct β-catenin phosphorylation.
PLoS ONE 7, e35826 (2012).
51. Joksimovic, M. & Awatramani, R. Wnt/β-catenin signaling in midbrain dopa-
minergic neuron speciﬁcation and neurogenesis. J. Mol. Cell Biol. 6, 27–33
(2014).
52. Lahti, L., Achim, K. & Partanen, J. Molecular regulation of GABAergic neuron
differentiation and diversity in the developing midbrain. Acta Physiol. 207,
616–627 (2013).
53. Andersson, E. et al. Identiﬁcation of intrinsic determinants of midbrain dopa-
mine neurons. Cell 124, 393–405 (2006).
54. Olander, S., Nordström, U., Patthey, C. & Edlund, T. Convergent Wnt and FGF
signaling at the gastrula stage induce the formation of the isthmic organizer.
Mech. Dev. 123, 166–176 (2006).
55. Domingos, P. M. et al. The Wnt/beta-catenin pathway posteriorizes neural
tissue in Xenopus by an indirect mechanism requiring FGF signalling. Dev. Biol.
239, 148–160 (2001).
56. Canning, C. A., Lee, L., Irving, C., Mason, I. & Jones, C. M. Sustained interactive
Wnt and FGF signaling is required to maintain isthmic identity. Dev. Biol. 305,
276–286 (2007).
57. Li, X. J. et al. Speciﬁcation of motor neurons from human embryonic stem
cells. Nat. Biotechnol. 23, 215–221 (2005).
58. Zhang, S. C. Neural subtype speciﬁcation from embryonic stem cells. Brain
Pathol. 16, 132–142 (2006).
59. Morales, M. & Root, D. H. Glutamate neurons within the midbrain dopamine
regions. Neuroscience 282, 60–68 (2014).
60. Doherty, D., Millen, K. J. & Barkovich, A. J. Midbrain and hindbrain malforma-
tions: advances in clinical diagnosis, imaging, and genetics. Lancet Neurol. 12,
381–393 (2013).
Kim et al. Experimental & Molecular Medicine (2018) 50:24 Page 13 of 13
Ofﬁcial journal of the Korean Society for Biochemistry and Molecular Biology
